Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2

Conditions

Polycystic Ovary Syndrome 2Obesity 2

Interventions

Metformin 17Liraglutide 5semaglutide 3Exercise 3Exenatide 3Diet, Mediterranean 3Dexamethasone 3Caloric Restriction 3Ovidrel 2Mindfulness-Based Stress Reduction 2Hydrocortisone 2Electroacupuncture 2Docosahexaenoic Acids 2Diet 2Cosyntropin 2sibutramine 1penclomedine 1mirabegron 1lime 1licogliflozin 1dapagliflozin 1Vitamin D 1Utrogestan 1Topiramate 1Tirzepatide 1Therapeutics 1Testosterone 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Cosyntropin × Other × Clear all
NCT01421797 2023-10-27

JCM022

University of Virginia

Phase NA Unknown
84 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT01422733 2018-07-19

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡